ITI Pharma and Healthcare Fund - Regular Plan - Growth Option

Category: Equity: Sectoral-Pharma and Healthcare
Launch Date: 08-11-2021
Asset Class:
Benchmark: NIFTY Healthcare TRI
Expense Ratio: 2.34% As on (31-01-2024)
Status: Open Ended Schemes
Minimum Investment: 5000.0
Minimum Topup: 1000.0
Total Assets: 151.43 Cr As on (31-01-2024)
Turn over:
NAV as on 20-02-2024

13.7332

0.02 (0.1384%)

CAGR Since Inception

14.89%

NIFTY Healthcare TRI 15.09%

PERFORMANCE of ITI Pharma and Healthcare Fund - Regular Plan - Growth Option

Scheme Performance (%) Data as on - 20-02-2024

1-Year Ret (%) 3-Yrs Ret (%) 5-Yrs Ret (%) 10-Yrs Ret (%) Since Launch Ret (%)
ITI Pharma and Healthcare Fund - Regular Plan - Growth Option 52.01 - - - 14.89
NIFTY Healthcare TRI 56.6 19.17 20.47 12.13 15.09
Equity: Sectoral-Pharma and Healthcare 56.08 18.82 25.08 15.9 19.32

Yearly Performance (%)

Nav Movement

Fund Managers

Dhimant Shah, Rohan Korde, Tanay Gabhawala

Investment Objective

The scheme seeks to generate long term capital appreciation through investing in equity and equity related securities of companies engaged in Pharma and Healthcare.

RETURNS CALCULATOR for ITI Pharma and Healthcare Fund - Regular Plan - Growth Option

Growth of 10000 In SIP (Fund vs Benchmark)

Amount :
Period :
Start :
End :

Growth of 10000 In LUMPSUM (Fund vs Benchmark)

Amount :
Start :

Rolling Returns

Rolling returns are the annualized returns of the scheme taken for a specified period (rolling returns period) on every day/week/month and taken till the last day of the duration. In this chart we are showing the annualized returns over the rolling returns period on every day from the start date and comparing it with the benchmark. Rolling returns is the best measure of a fund's performance. Trailing returns have a recency bias and point to point returns are specific to the period in consideration. Rolling returns, on the other hand, measures the fund's absolute and relative performance across all timescales, without bias.

Riskometer

Key Performance and Risk Statistics of ITI Pharma and Healthcare Fund - Regular Plan - Growth Option

Key Statistics Volatility Sharpe Ratio Alpha Beta Yield to Maturity Average Maturity
ITI Pharma and Healthcare Fund - Regular Plan - Growth Option 14.52 - -
Equity: Sectoral-Pharma and Healthcare - - - - - -

PEER COMPARISION of ITI Pharma and Healthcare Fund - Regular Plan - Growth Option

Period
Data as on - 20-02-2024
Scheme Name Launch
Date
1-Year
Ret (%)
2-Yrs
Ret (%)
3-Yrs
Ret (%)
5-Yrs
Ret (%)
10-Yrs
Ret (%)
ITI Pharma and Healthcare Fund - Regular Plan - Growth Option 08-11-2021 52.01 21.14 0.0 0.0 0.0
ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund - Cumulative Option 25-07-2018 61.97 25.51 20.49 25.82 0.0
Aditya Birla Sun Life Pharma and Healthcare Fund-Regular-Growth 05-07-2019 61.9 22.98 18.95 0.0 0.0
Nippon India Pharma Fund-Growth Plan-Growth Option 01-06-2004 60.25 24.43 20.58 24.29 17.68
SBI Healthcare Opportunities Fund - Regular Plan -Growth 14-07-1999 58.56 26.89 20.94 25.35 15.86
Tata India Pharma & Healthcare Fund-Regular Plan-Growth 28-12-2015 57.13 23.35 19.64 24.57 0.0
UTI Healthcare Fund - Regular Plan - Growth Option 05-08-2005 56.3 21.46 17.95 22.85 14.15
Mirae Asset Healthcare Fund -Regular Growth 10-07-2018 53.07 19.61 19.04 25.5 0.0
DSP Healthcare Fund - Regular Plan - Growth 05-11-2018 51.0 23.06 18.08 27.18 0.0
LIC MF Healthcare Fund-Regular Plan-Growth 22-02-2019 48.63 16.6 13.75 0.0 0.0

PORTFOLIO ANALYSIS of ITI Pharma and Healthcare Fund - Regular Plan - Growth Option

Asset Allocation (%)